“Contrast nephropathy” in renal transplantation:Is it real?

查看全文 作　　者：Fedaey Mohammed [1,2]Abbas;Bridson M [2]Julie;Ajay [2,3]Sharma;Ahmed [2,4]Halawa

机构地区：[1]Nephrology Department, Jaber El Ahmed Military Hospital;[2]Faculty of Health and Science, University of Liverpool, Institute of Learning and Teaching, School of Medicine;[3]Royal Liverpool University Hospital;[4]Sheffield Teaching Hospitals

出　　处：《World Journal of Transplantation》索引2016年第6卷第4期,共7页

摘　　要：The risk of contrast-induced nephropathy(CIN) in renal transplant recipients is increased in diabetics, patients with impaired basal kidney function, patients in shock, patients presenting with acute emergency and in old age recipients. Approximately one-third of all hospitalized patients with acute kidney injury is attributed to CIN. In the United States, it is the third leading cause of hospital-acquired renal failure. Therefore, efforts should be directed to minimize CIN-related morbidity and mortality as well as to shorten hospital stay. While the role of peri-procedural prophylactic hydration with saline is unequivocal; the use of acetyl cysteine is not based on robust evidence. The utility of theophylline, aminophylline, calcium channel blockers, natriuretic peptide, and diuretics does not have proven role in attenuating CIN incidence. We aim to analyze the evidence for using various protocols in published literature to limit CIN-associated morbidity and mortality, particularly during surveillance of the renal allograft survival. 关键词：CONTRAST RENAL TRANSPLANTATION NEPHROPATHY

相关文献

参考文献（37）
引证文献（1）
耦合文献（0）

参考文献(37)

引证文献(1)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

“Contrast nephropathy” in renal transplantation:Is it real?

参考文献(37)

引证文献(1)

用户提示